title: Difficult hGH treatment in a patient with type III glycogen storage disease.
abstract: The case of a boy affected by type III glycogen storage disease and total GH deficiency is reported. Substitutive treatment with hGH caused an extreme elevation of blood lipids. His lipid profile returned near to basal values 1 month after treatment was discontinued. The association of growth hormone and amylo-1-6-glucosidase deficiencies is unusual and difficult to treat; however growth hormone deficiency should be considered in patients with hepatic glycogenoses and severe growth retardation.
authors.forename: D
authors.initials: D
authors.lastname: Larizza
authors.forename: G
authors.initials: G
authors.lastname: Maggiore
authors.forename: D
authors.initials: D
authors.lastname: Marzani
authors.forename: M
authors.initials: M
authors.lastname: Maghnie
authors.forename: R
authors.initials: R
authors.lastname: Ciceri
mesh_terms: D000293:Adolescent; D002784:Cholesterol / Q000097:blood; D002914:Chylomicrons / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006008:Glycogen Storage Disease / Q000378:metabolism*; D006010:Glycogen Storage Disease Type III / Q000150:complications / Q000378:metabolism*; D006130:Growth Disorders / Q000188:drug therapy* / Q000209:etiology; D013006:Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects* / Q000172:deficiency; D006801:Humans; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D013997:Time Factors
chemical_list: D002914:Chylomicrons; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D013006:Growth Hormone; D002784:Cholesterol